Martin Buckland serves as Executive at Astex Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Martin Buckland has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 11, 2013 involved transacting 5,963 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 11, 2013 | ASTX | $0 | Tender | 5,963 | $N/A | Discretionary |
Martin Buckland currently holds 0 shares of Astex Pharmaceuticals, Inc (ASTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin Buckland has been a net neutral trader of ASTX stock. They have purchased $0 and sold $0 worth of shares.
Martin Buckland's most recent insider trade was on Oct 11, 2013, when they sold 5,963 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted